| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cardiovascular Division (O.Z., G.O., G.S., E.L., J.P.), Brigham and Womens Hospital, Harvard University, Boston, Massachusetts 02115; Merck Research Laboratories (J.P.B.), Rahway, New Jersey; Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University (G.T., N.I.K., G.G.D.), and Department of Biochemistry (N.I.K.), Tufts University School of Medicine, Boston, Massachusetts 02111
Address all correspondence and requests for reprints to: Jorge Plutzky, M.D., Brigham and Womens Hospital, 77 Avenue Louis Pasteur, NRB 742D, Boston, Massachusetts 02115. E-mail: jplutzky{at}rics.bwh.harvard.edu.
ß-Carotene and its metabolites exert a broad range of effects, in part by regulating transcriptional responses through specific nuclear receptor activation. Symmetric cleavage of ß-carotene can yield 9-cis retinoic acid (9-cisRA), the natural ligand for the nuclear receptor RXR, the obligate heterodimeric partner for numerous nuclear receptor family members. A significant portion of ß-carotene can also undergo asymmetric cleavage to yield apocarotenals, a series of poorly understood naturally occurring molecules whose biologic role, including their transcriptional effects, remains essentially unknown. We show here that ß-apo-14'-carotenal (apo14), but not other structurally related apocarotenals, represses peroxisome proliferator-activated receptors (PPAR) and RXR activation and biologic responses induced by their respective agonists both in vitro and in vivo. During adipocyte differentiation, apo14 inhibited PPAR
target gene expression and adipogenesis, even in the presence of the potent PPAR
agonist BRL49653. Apo14 also suppressed known PPAR
responses, including target gene expression and its known antiinflammatory effects, but not if PPAR
agonist stimulation occurred before apo14 exposure and not in PPAR
-deficient cells or mice. Other apocarotenals tested had none of these effects. These data extend current views of ß-carotene metabolism to include specific apocarotenals as possible biologically active mediators and identify apo14 as a possible template for designing PPAR and RXR modulators and better understanding modulation of nuclear receptor activation. These results also suggest a novel model of molecular endocrinology in which metabolism of a parent compound, ß-carotene, may alternatively activate (9-cisRA) or inhibit (apo14) specific nuclear receptor responses.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
S. Hessel, A. Eichinger, A. Isken, J. Amengual, S. Hunzelmann, U. Hoeller, V. Elste, W. Hunziker, R. Goralczyk, V. Oberhauser, et al. CMO1 Deficiency Abolishes Vitamin A Production from beta-Carotene and Alters Lipid Metabolism in Mice J. Biol. Chem., November 16, 2007; 282(46): 33553 - 33561. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |